The Denver school-based adolescent hepatitis B vaccination program: a cost analysis with risk simulation.

Abstract

The cost per dose of the school-based program was significantly less than that of the network HMO-based program, because in the school program government-purchased vaccine was available at a lower cost and parents did not incur work-loss costs.